

Study with the several resources on Docsity
Earn points by helping other students or get them with a premium plan
Prepare for your exams
Study with the several resources on Docsity
Earn points to download
Earn points by helping other students or get them with a premium plan
Week 3 iHuman Assignment Reflection Worksheet
Typology: Exams
1 / 3
This page cannot be seen from the preview
Don't miss anything!


Week 3 iHuman Assignment Reflection Worksheet Gabrielle Johnson Chamberlain University College of Nursing NR 509: Advanced Physical Assessment Dr. Nancy Baltz March 22, 2026 Week 3 iHuman Assignment Reflection Worksheet In cases where the patient is uninsured, the management plan should be adapted to provide cost-effective and accessible care while maintaining safe, evidence-based treatment. For patients presenting with symptoms consistent with streptococcal pharyngitis, the cost of diagnostic testing, such as a rapid strep test, may be prohibitive. In such situations, clinical decision tools like the Centor criteria can guide treatment decisions in the absence of confirmatory testing. Medication selection should also be adjusted to prioritize affordability.
Amoxicillin is an appropriate first-line treatment due to its low cost and proven effectiveness. Over-the-counter medications, including acetaminophen or ibuprofen, are recommended for symptom relief because they are widely available and inexpensive. Patient education should emphasize non-pharmacologic interventions, including adequate hydration, rest, and infection prevention strategies. Follow-up care is often more challenging for uninsured patients; therefore, providing clear return precautions is essential. Patients should be instructed to seek medical attention if symptoms worsen or complications arise. Referrals to low-cost clinics or community health resources should also be considered to support continuity of care. Overall, the management approach should prioritize minimizing financial burden while ensuring safe, guideline-based care for suspected streptococcal pharyngitis (Centers for Disease Control and Prevention, 2024). References Centers for Disease Control and Prevention. (2024, March 1). Clinical guidance for group A streptococcal pharyngitis (strep throat).